Evaluation of Antibiotic Use in Pediatric Inpatients at one of Bandung Regional Hospitals in August 2023

Putri Maharani, Imam A. Wicaksono, Falerina Puspita, Hijrah M. Zainudin

Abstract


Infectious diseases are a major concern in the field of health, especially in developing countries like Indonesia. Children are vulnerable to infections because their immune systems are not fully developed. Proper management is necessary for the prevention and treatment of infectious diseases in pediatric patients. Antibiotics are the primary choice for addressing bacterial infections. However, the increased use of antibiotic can contribute to high levels of antimicrobial resistance (AMR), rendering infection treatment ineffective. The evaluation of antibiotic use can be conducted through the ATC/DDD method, which focuses on the quantity and types of antibiotics used. Although this method provides a quantitative overview, a qualitative approach using the Gyssens method and interviews with relevant parties is necessary for a more in-depth understanding of the rationality of antibiotic use. This study aims to comprehend the patterns of antibiotic use in pediatric inpatients at one of Bandung Regional Hospitals during August 2023. Using a retrospective observational approach, data were collected and processed using the ATC/DDD method. The evaluation results show that cephalosporins is the most commonly used antibiotic group, with cefotaxime being the dominant antibiotic administered intravenously. Quantitative evaluation indicates variations in DDD/100 patient days among different antibiotics, with ciprofloxacin having the highest value and amikacin the lowest. For a comprehensive understanding, qualitative research using the Gyssens method and interviews is necessary to strengthen the evaluation results of antibiotic use. Ultimately, this study provides a thorough perspective on antibiotic use in pediatric inpatients, supporting efforts to control antimicrobial resistance and promote more judicious antibiotic selection.


Keywords


antibiotics; pediatrics; antibiotic use evaluation; WHO indicator ATC/DDD.

Full Text:

PDF

References


Carolina M, Widayati A. Evaluasi Penggunaan Antibiotika Dengan Metode Ddd (Defined Daily Dose) Pada Pasien Anak Rawat Inap Di Sebuah Rumah Sakit Pemerintah Di Yogyakarta Periode Januari – Juni 2013. Media Farmasi: Jurnal Ilmu Farmasi [Internet]. 2014 Mar 1;11(1). Available from: http://journal.uad.ac.id/index.php/Media-Farmasi/article/view/1400 [Accessed on December 2023]

Djaja S, Sulistiyowati N. Pola Penyebab Kematian Kelompok Bayi Dan Anak Balita, Hasil Sistem Registrasi Kematian Di Indonesia Tahun 2012. Indonesian Journal of Health Ecology. 2012;13(3):265–72.

Williams-Nguyen J, Sallach JB, Bartelt-Hunt S, Boxall AB, Durso LM, McLain JE, et al. Antibiotics and Antibiotic Resistance in Agroecosystems: State of the Science. Journal of Environmental Quality. 2016 Mar;45(2):394–406.

World Health Organization (WHO). Antimicrobial Resistance [Internet]. 2023 [cited 2023 Dec 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance [Accessed on December 2023]

Abushaheen MA, Muzaheed, Fatani AJ, Alosaimi M, Mansy W, George M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Disease-a-Month. 2020 Jun;66(6):100971.

Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology. 2018;4(3):482–501.

Kementrian Kesehatan RI. Petunjuk Teknis Standar Pelayanan Kefarmasian di Rumah Sakit. Jakarta: Kementrian Kesehatan RI; 2021.

World Health Organization (WHO). WHO Collaborating Centre for Drug Statistics Methodology [Internet]. 2023. Available from: https://www.whocc.no/ [Accessed on December 2023]

Word Health Organization (WHO). The ATC/ DDD Methodology [Internet]. 2023 Available from: https://www.who.int/tools/atc-ddd-toolkit/ [Accessed on December 2023]

Kementrian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia nomor 27 tahun 2017 tentang Pedoman Pencegahan dan Pengendalian Infeksi di Fasilitas Pelayanan Kesehatan. Jakarta; 2017.

Kementrian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia nomor 8 Tahun 2015 tentang Program Pengendalian Resistensi Antimikroba di Rumah Sakit. Jakarta; 2015

Rachmawati S, Masito DK, Rachmawati E. Evaluasi Penggunaan Antibiotik pada Pasien Anak Rawat Inap di RSD Dr. Soebandi Jember. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal). 2020 Sep 30;6(2).

Mathew R, Sayyed H, Behera S, Maleki K, Pawar S. Evaluation of antibiotic prescribing pattern in pediatrics in a tertiary care hospital. The Avicenna Medical Journal. 2021 Jan;11(01):15–9.

El-Dahiyat F, Salah D, Alomari M, Elrefae A, Jairoun AA. Antibiotic Prescribing Patterns for Outpatient Pediatrics at a Private Hospital in Abu Dhabi: A Clinical Audit Study. Antibiotics. 2022 Nov 22;11(12):1676.

Pottegård A, Broe A, Aabenhus R, Bjerrum L, Hallas J, Damkier P. Use of antibiotics in children: a Danish nationwide drug utilization study. The Pediatric Infectious Disease Journal. 2015 Feb;34(2):e16-22.

de Bie S, Kaguelidou F, Verhamme KMC, De Ridder M, Picelli G, Straus SMJM, et al. Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing. The Pediatric Infectious Disease Journal. 2016 Dec;35(12):1317–23.

Tipper DJ. Mode of action of beta-lactam antibiotics. Pharmacol Ther. 1985;27(1):1–35.

Peechakara B V, Basit H, Gupta M. Ampicillin [Internet]. National Library of Medicine. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519569/ [Accessed on July 2024]

Bui T, Patel P, Preuss C V. Cephalosporins [Internet]. National Library of Medicine. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551517/ [Accessed on July 2024]

Tartaglione TA, Polk RE. Review Of The New Second-Generation Cephalosporins: Cefonicid, Ceforanide, And Cefuroxime. Drug Intelligence & Clinical Pharmacy. 1985 Mar;19(3):188–98

Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Cefepime: A New Fourth-Generation Cephalosporin. American Journal of Health-System Pharmacy. 1994 Feb 15;51(4):463–77; quiz 541–2

Lupia T, Pallotto C, Corcione S, Boglione L, De Rosa FG. Ceftobiprole Perspective: Current and Potential Future Indications. Antibiotics (Basel). 2021 Feb 8;10(2).

Hsu WH, Hsu CK, Lai CC. Ceftobiprole medocaril for the treatment of pneumonia. Expert Review of Anti-infective Therapy. 2023 Jun;21(6):551–63.

Mahmoud E, Al Mansour S, Bosaeed M, Alharbi A, Alsaedy A, Aljohani S, et al. Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series. Infection and Drug Resistance. 2020;13:2667–72.

Ikatan Dokter Anak Indonesia. Buku Ajar lnfeksi & Pediatri Tropis (2nd ed.). Jakarta: Badan Penerbit Ikatan Dokter Anak Indonesia; 2008.

Rahayuningsih N. Evaluasi Penggunaan Antibiotik Sefalosporin Di Ruang Perawatan Bedah Salah Satu Rumah Sakit Di Kabupaten Tasikmalaya. Jurnal Kesehatan Bakti Tunas Husada: Jurnal Ilmu-ilmu Keperawatan, Analis Kesehatan dan Farmasi. 2017 Feb 26;17(1):139.

Aberg JA, C.F L, L.L A, M. P G, L. L L. Drug Information Handbook 17th edition. Hudson: Lexi-Comp for the American Pharmacists Association; 2009.

Babu TA, Sharmila V. Cefotaxime-induced near-fatal anaphylaxis in a neonate: A case report and review of literature. Indian Journal Pharmacology. 2011 Sep;43(5):611–2.

Lestari B, Soeharto S, Nurdiana, Permatasari N, Khotimah H, Nugrahenny D, et al. Buku Ajar Farmakologi Dasar. Malang: Universitas Brawijaya Press; 2017.

Hollingworth S, Kairuz T. Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data. Pharmacy. 2021 Mar 17;9(1):60.

Montecatine-Alonso E, Mejías-Trueba M, Goycochea-Valdivia WA, Chavarri-Gil E, Fernández-Llamazares CM, Dolz E, et al. Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population. Antibiotics. 2023 Jan 31;12(2):276.

Kementrian Kesehatan RI. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik. Jakarta: Kementrian Kesehatan RI; 2011.




DOI: https://doi.org/10.15416/pcpr.v9i1.52984

Refbacks

  • There are currently no refbacks.


                                                                         
Pharmacology and Clinical Pharmacy Research is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
 
                                                                      VIEW VISITOR STATS